| Survivin: a unique target for tumor therapy H Garg, P Suri, JC Gupta, GP Talwar, S Dubey Cancer cell international 16, 1-14, 2016 | 506 | 2016 |
| Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction JG Abelin, D Harjanto, M Malloy, P Suri, T Colson, SP Goulding, ... Immunity 51 (4), 766-779. e17, 2019 | 217 | 2019 |
| The mutation-associated neoantigen functional expansion of specific T cells (MANAFEST) assay: a sensitive platform for monitoring antitumor immunity L Danilova, V Anagnostou, JX Caushi, JW Sidhom, H Guo, HY Chan, ... Cancer immunology research 6 (8), 888-899, 2018 | 160 | 2018 |
| Compartmental analysis of T-cell clonal dynamics as a function of pathologic response to neoadjuvant PD-1 blockade in resectable non–small cell lung cancer J Zhang, Z Ji, JX Caushi, M El Asmar, V Anagnostou, TR Cottrell, ... Clinical Cancer Research 26 (6), 1327-1337, 2020 | 131 | 2020 |
| Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1 KN Smith, NJ Llosa, TR Cottrell, N Siegel, H Fan, P Suri, HY Chan, H Guo, ... Journal for immunotherapy of cancer 7, 1-8, 2019 | 45 | 2019 |
| Species-specific CD4+ T cells enable prediction of mucosal immune phenotypes from microbiota composition MP Spindler, I Mogno, P Suri, GJ Britton, JJ Faith Proceedings of the National Academy of Sciences 120 (12), e2215914120, 2023 | 10 | 2023 |
| Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction JG Abelin, D Harjanto, M Malloy, P Suri, T Colson, SP Goulding, ... Immunity 54 (2), 388, 2021 | 9 | 2021 |
| 824 Defining the determinants of immune response in DNA homologous recombination deficient tumors N Vaninov, P Suri, CA Ribeiro, J Habib, RM Samstein Journal for ImmunoTherapy of Cancer 12 (Suppl 2), 2024 | | 2024 |
| Abstract PR005: Identification of DNA Damage Repair genes controlling the immune landscape of breast tumors via spatial functional genomics P Suri, J Habib, G Mollaoglu, L Pia, A Baccarini, B Brown, R Samstein Cancer Research 84 (1_Supplement), PR005-PR005, 2024 | | 2024 |
| Identification of DNA Damage Repair genes controlling the immune landscape of breast tumors via spatial functional genomics P Suri, J Habib, G Mollaoglu, L Pia, A Baccarini, B Brown, R Samstein CANCER RESEARCH 84 (1), 2024 | | 2024 |
| 201 BNT221, an autologous neoantigen-specific T-cell product for adoptive cell therapy of metastatic ovarian cancer C Arieta, D Velez, S Hannes, S Meda, B McCarthy, D Lenkala, D Harjanto, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | | 2021 |
| Enhanced HLA-II epitope prediction for immunotherapy with novel proteomics and genomics approaches. D Harjanto, JG Abelin, M Malloy, P Suri, T Colson, SP Goulding, ... CANCER IMMUNOLOGY RESEARCH 8 (3), 97-97, 2020 | | 2020 |
| Abstract B23: Enhanced HLA-II epitope prediction for immunotherapy with novel proteomics and genomics approaches D Harjanto, JG Abelin, M Malloy, P Suri, T Colson, SP Goulding, ... Cancer Immunology Research 8 (3_Supplement), B23-B23, 2020 | | 2020 |
| MA04. 11 Neoantigen Targeting and T Cell Reshaping in Resectable NSCLC Patients Treated with Neoadjuvant PD-1 Blockade M El Asmar, J Zhang, J Caushi, Z Ji, V Anagnostou, T Cottrell, HY Chan, ... Journal of Thoracic Oncology 13 (10), S370, 2018 | | 2018 |
